- This event has passed.
Aug 21, 2019 @ 7:00 pm - 8:30 pmFree
Two HIV activists who took part in early gene therapy trials to cure or control HIV and the scientist who led that research will be talking about their experiences which helped usher in a new scientific era at “Medical Angels”, https://bit.ly/2KybECa a free community forum led by people living with HIV on Wednesday, August 21 at 7PM at the Central Branch of the Seattle Public Library.
“If we’re going to cure HIV,” said Matt Chappell, one of the two men in a trial to have his immune cells edited to make them resistant to HIV, “this is how it’s going to happen.”
In 2014, scientists removed some of his blood cells, disabled a gene to help them resist HIV, and returned these “edited” cells to him. While this procedure did not cure Chappell, it did allow his body to suppress the virus without medications.
“I’ve been off medications now for five years,” he said.
Chappell’s case is rare. Most people in these early experiments still needed medicines to keep HIV suppressed. But even some of these people saw dramatic improvements.
Matt Sharp, a veteran of the AIDS Coalition to Unleash Power, (ACT UP) was diagnosed with HIV in 1988. While taking HIV medicines, Sharp never saw his T cell count rise, despite fully suppressing the virus in his blood.
But after a single infusion of his own edited cells during the trial, Sharp saw his count jump to normal, healthy levels. Gene therapy brought long-term improvements to his immune-system health. Sharp thinks participation in the study was worth it, but he still takes daily pills to keep the virus under control.
These two men and the researcher who led these gene-editing experiments will answer audience questions about these unique results during a public forum on August 21 hosted by members of the defeatHIV Community Advisory Board (CAB).
The defeatHIV CAB recently collaborated with social scientists to conduct focus groups among HIV- positive African Americans in the Pacific Northwest on the acceptability of cell and gene therapies for curing HIV.
From these investigations with local people living with HIV, they learned that a majority of people expressed reluctance to take part in this type of research, yet wanted to talk to individuals who had undergone cell & gene therapy to hear about their experiences directly. This forum on August 21 is the CAB’s attempt to use the findings of their research to build on the work thus far to educate people about cell and gene therapy approaches to cure HIV.
The defeatHIV Community Advisory Board’s mission is to serve as a communication link and mobilize HIV cure researchers, their institutions and our communities to work together to cure HIV, ensuring that input from people living with HIV is accounted for in cure-related research of defeatHIV. As a part of Fred Hutch, defeatHIV is an NIH-funded Martin Delaney Collaboratory working at the forefront of cell and gene therapy research to develop curative therapies for HIV. For more information, visit www.defeatHIV.org or follow @defeatHIV on Twitter.
Calendar event posts are submitted by members of the public and/or by organizations unaffiliated with The Seattle Globalist. Questions about individual events, postings and images used in calendar items should be directed toward the event organizers, who are responsible for the content.